Table 1 Demographic and clinical characteristics of patient
Characteristics | POAF(n = 5) | Non-AF(n = 5) | P value |
|---|---|---|---|
Age, years | 70.8 ± 4.6 | 69.0 ± 6.0 | 0.609 |
Male, n,% | 3 (60.0%) | 3 (60.0%) | 1.000 |
BMI, Kg/m2 | 24.4 ± 1.5 | 25.8 ± 1.4 | 0.168 |
Diabetes, n,% | 2 (40.0%) | 3 (60.0%) | 1.000 |
Hypertension, n,% | 3 (60.0%) | 4 (80.0%) | 1.000 |
Leukocytes, × 109/L | 6.0 ± 1.3 | 6.3 ± 1.3 | 0.710 |
Neutrophils | 3.5 ± 0.8 | 3.6 ± 1.0 | 0.822 |
Lymphocytes | 1.7 ± 0.6 | 2.0 ± 0.5 | 0.340 |
Neutrophil ratio | 56.1 (54.4–62.1) | 56.1 (53.8–58.2) | 0.690 |
Lymphocytes ratio | 27.9 (26.0–32.9) | 34.1 (32.8–35.9) | 0.421 |
Hemoglobin, g/L | 136.6 ± 23 | 135.2 ± 22.2 | 0.925 |
BNP, ng/L | 103.8 ± 75.5 | 79.0 ± 58.7 | 0.578 |
GLU, | 6.7 ± 3.5 | 7.6 ± 2.8 | 0.666 |
HbA1C | 6.1 ± 0.6 | 6.9 ± 1.4 | 0.083 |
TC, mmol/L | 2.8 ± 1.0 | 4.6 ± 0.5 | 0.005* |
LDL, mmol/L | 1.6 ± 0.8 | 2.6 ± 0.8 | 0.100 |
HDL, mmol/L | 0.76 ± 0.2 | 0.82 ± 0.1 | 0.584 |
TG, mmol/L | 1.0 ± 0.5 | 2.3 ± 0.8 | 0.013* |
Lpa, mmol/L | 19.2 ± 12.7 | 14.9 ± 7.4 | 0.536 |
BUN, mmol/L | 5.5 ± 1.4 | 6.9 ± 1.4 | 0.171 |
Scr, μmol/L | 60.8 ± 13.1 | 77.0 ± 18.9 | 0.153 |
LVEDD, mm | 50 ± 2 | 45.8 ± 2.5 | 0.019 |
LVEF, % | 53.6 ± 10.4 | 62.8 ± 2.2 | 0.056 |
LAD, mm | 41.9 ± 3.7 | 39.9 ± 1.9 | 0.316 |
RAD, mm | 40.3 ± 3.4 | 38.8 ± 2.0 | 0.425 |
Anastomoses | 2.6 ± 1.5 | 2.2 ± 1.1 | 0.645 |
Drainage-1 | 362.0 ± 88.1 | 388 ± 65.7 | 0.611 |
Drainage-T | 977.0 ± 558.3 | 958.0 ± 306.5 | 0.948 |
Length of ICU stay | 5.4 ± 1.5 | 4.6 ± 2.1 | 0.506 |